Efficacy and Learning Skill After OROS Methylphenidate Treatment in Adolescents With Attention-Deficit/Hyperactivity Disorder: A 12-week, Multi-center, Open-label Study.
Phase of Trial: Phase IV
Latest Information Update: 30 Jul 2013
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Janssen
- 15 Jul 2010 Actual end date added to 1 Apr 2010 as reported by ClinicalTrials.gov.
- 15 Jul 2010 Actual initiation date (Jul 2008) added as reported by ClinicalTrials.gov.
- 15 Jul 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.